According to Rauch and Kofler [13], the galanin peptide expression is studied in pheochromocytoma, pituitary adenoma, neuroblastic tumors, gastrointestinal cancer, squamous cell carcinoma, brain tumors, melanoma, breast cancer, and embryonal carcinoma. Here, GAL is linked to hereditary pheochromocytoma-paraganglioma.